Eurofins Scientific SE
Stock Details
Is it expensive?
Market Cap
11.34B
Trailing P/E Ratio
25.82
Forward P/E Ratio
14.16
PEG Ratio
--
15.16B
10.42
Price-to-Sales (TTM)
1.58
3.28
20.05
Is it profitable?
7.30B
Net Profit Margin (TTM)
6.51%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
2.55
9.50%
Is it growing?
4.30%
22.90%
Is it risky?
0.85
96.84
4.43B
1.09
Who owns it?
35.46%
36.50%
0.00%
176.70M
112.79M
Does it pay?
4.44%
23.53%
Apr 28, 2026
--
How much cash?
794.20M
1.40B
492.52M
4.50
- Price (EOD)
- 64.92
- Percent Change
- -0.12 (0.18%)
- Previous Close
- 65.04
- Open
- 64.90
- Low
- 64.88
- High
- 65.96
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€64.92
From 52W Low
+18.34%
From 52W High
-12.65%
Today
-0.18%
1Y Change
+13.97%
6M
€58.82
3M
€65.66
1M
€60.00
Today
€64.92
From 52W Low
+18.34%
From 52W High
-12.65%
Today
-0.18%
1Y Change
+13.97%
6M
€58.82
3M
€65.66
1M
€60.00
Today
€64.92
Fairly Priced
within its 1-year price range
€64.92
Multi-Timeframe Analysis (MTA)
Uptrend
Most timeframes point up. One conflicting period introduces some uncertainty, but the overall direction is positive. Weaker than a Strong Uptrend, but still a bullish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+8.2%
3M
-1.1%
6M
+10.4%
1Y
+14.0%
Rate of Change (ROC)
Accelerating
Price is rising 10.3x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Below Average
Fewer shares than usual are trading today. Low volume moves are less reliable. Price can drift without real conviction behind it. As reflected in the Relative Volume (RVOL) below.
- Name
- Eurofins Scientific SE
- Founded
- 1987
- CEO
- Gilles G. Martin
- Employees
- 65,694
- Fiscal Year End
- Dec 31, 2025
- Address
23 Val Fleuri
Luxembourg
MI
1526
Luxembourg
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.eurofins.com
Indicators
Operating Cash Flow
1.40B
Net Income
416.10M
Real Earnings
3.36
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
1.40B
Net Income
416.10M
Real Earnings
3.36
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
11.34B
Trailing P/E Ratio
25.82
Forward P/E Ratio
14.16
PEG Ratio
--
15.16B
10.42
Price-to-Sales (TTM)
1.58
3.28
20.05
Is it profitable?
7.30B
Net Profit Margin (TTM)
6.51%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
2.55
9.50%
Is it growing?
4.30%
22.90%
Is it risky?
0.85
96.84
4.43B
1.09
Who owns it?
35.46%
36.50%
0.00%
176.70M
112.79M
Does it pay?
4.44%
23.53%
Apr 28, 2026
--
How much cash?
794.20M
1.40B
492.52M
4.50
- Price (EOD)
- 64.92
- Percent Change
- -0.12 (0.18%)
- Previous Close
- 65.04
- Open
- 64.90
- Low
- 64.88
- High
- 65.96
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€64.92
From 52W Low
+18.34%
From 52W High
-12.65%
Today
-0.18%
1Y Change
+13.97%
6M
€58.82
3M
€65.66
1M
€60.00
Today
€64.92
From 52W Low
+18.34%
From 52W High
-12.65%
Today
-0.18%
1Y Change
+13.97%
6M
€58.82
3M
€65.66
1M
€60.00
Today
€64.92
Fairly Priced
within its 1-year price range
€64.92
Multi-Timeframe Analysis (MTA)
Uptrend
Most timeframes point up. One conflicting period introduces some uncertainty, but the overall direction is positive. Weaker than a Strong Uptrend, but still a bullish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+8.2%
3M
-1.1%
6M
+10.4%
1Y
+14.0%
Rate of Change (ROC)
Accelerating
Price is rising 10.3x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Below Average
Fewer shares than usual are trading today. Low volume moves are less reliable. Price can drift without real conviction behind it. As reflected in the Relative Volume (RVOL) below.
- Name
- Eurofins Scientific SE
- Founded
- 1987
- CEO
- Gilles G. Martin
- Employees
- 65,694
- Fiscal Year End
- Dec 31, 2025
- Address
23 Val Fleuri
Luxembourg
MI
1526
Luxembourg
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.eurofins.com